Illumina

Burning Rock, Illumina collaborate

Wednesday, August 26, 2015

Burning Rock, a Guangzhou, China-based diagnostics company, has entered into an agreement to develop advanced clinical applications for molecular diagnostics in oncology based on Illumina’s next-generation sequencing (NGS) technology. The collaboration highlights the  importance of genomics to improve healthcare in China.

[Read More]

Illumina launches Illumina SeqLab

Friday, July 17, 2015

Illumina, a San Diego-based provider of sequencing and array-based technologies, has launched Illumina SeqLab, an integrated solution for customers with HiSeq X Systems to enable large-scale human whole-genome sequencing operations. Designed to increase laboratory efficiency for population-scale, human whole-genome sequencing (HWGS), this new offering provides a complete solution for Illumina customers who need streamlined workflows with integrated sample tracking and fast and accurate analysis solutions.

[Read More]

Illumina adds European headquarters in Cambridge, England

Friday, June 26, 2015

Illumina, a San Diego-based provider of sequencing and array-based technologies, has signed a 20-year lease for a 155,000 square foot new and innovative scientific research building in Cambridge, England. The project will provide Illumina a collaborative environment and access to the highly skilled workforce in the dynamic research cluster anchored by Cambridge University.

[Read More]

Denali Therapeutics launches to study neurodegenerative disease treatments

Friday, May 15, 2015

Denali Therapeutics, a new California-based biotechnology company focused on developing effective therapies for neurodegenerative diseases, has launched with an initial investment commitment of $217 million. Denali is based on the collaboration of world-class scientists, industry experts and investors. Recent scientific insights into the genetic causes and biological processes underlying neurodegenerative disease, together with new translational medicine tools, offer an unprecedented opportunity to discover and develop effective medicines for Alzheimer’s disease, Parkinson’s disease, ALS and other neurodegenerative diseases.

[Read More]

Ab Sciex, Illumina collaborate to create multi-omics cloud-computing environment

Monday, October 6, 2014

Ab Sciex, a Framingham, Mass.-based global provider of mass spectrometry products, and San Diego, Calif.-based Illumina, a global provider of sequencing and array-based technologies, have announced the OneOmics project, an exclusive partnership to bring together SWATH-based next-generation proteomics (NGP) and next-generation sequencing (NGS) tools in a cloud computing environment.

[Read More]